Pembrolizumab followed by AVD in untreated early unfavorable and advanced stage classical Hodgkin lymphoma.
暂无分享，去创建一个
R. Advani | L. Gordon | J. Winter | J. Chmiel | A. Evens | G. Dillehay | B. Pro | Pamela Blair Allen | R. Karmali | R. Bayer | H. Savas | R. Eisner | Eric Mou | B. Palmer | J. Bearden | Kaitlyn L O'Shea | Kaitlyn L. O'Shea | Eric Mou